Distinguishing Asthma from Sarcoidosis: An Approach to a Problem that is not Always Solvable

References

• Olsson T, Björnstad-Pettersen H, Stjernberg NL. Bronchostenosis due to sarcoidosis: A cause of atelectasis and airway obstruction simulating pulmonary neoplasm and chronic obstructive pulmonary disease. Chest 1979 June; 75(6):663–666.
   PubMedGoogle Scholar
• Hadfield JW, Page RL, Flower CD, Stark JE. Localised airway narrowing in sarcoidosis. Thorax 1982 June; 37(6):443–447.
   PubMedGoogle Scholar
• Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: A prospective study. Chest 2001 July; 120(1):109–114.
   PubMed Web of Science ®Google Scholar
• Westcott JL, Noehren TH. Bronchial stenosis in chronic sarcoidosis. Chest 1973 June; 63(6):893–897.
   PubMedGoogle Scholar
• Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000 June; 174(6):1751–1757.
   PubMed Web of Science ®Google Scholar
• Mihailovic-Vucinic V, Zugic V, Videnovic-Ivanov J. New observations on pulmonary function changes in sarcoidosis. Curr Opin Pulm Med 2003 September; 9(5):436–441.
   PubMedGoogle Scholar
• Marcias S, Ledda MA, Perra R, Severino C, Rosetti L. Aspecific bronchial hyperreactivity in pulmonary sarcoidosis. Sarcoidosis 1994 September; 11(2):118–122.
   PubMedGoogle Scholar
• Bechtel JJ, Starr T 3rd, Dantzker DR, Bower JS. Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981 December; 124(6):759–761.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest 2001 September; 120(3):881–886.
   PubMed Web of Science ®Google Scholar
• Laitinen LA, Haahtela T, Kava T, Laitinen A. Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis. Eur J Respir Dis Suppl 1983; 131:267–284.
   PubMedGoogle Scholar
• Miller A, Teirstein AS, Jackler I, Chuang M, Siltzbach LE. Airway function in chronic pulmonary sarcoidosis with fibrosis. Amer Rev Respir Dis 1974 February; 109(2):179–189.
   PubMed Web of Science ®Google Scholar
• Criado E, Sánchez M, Ramírez J, Arquis P, de Caralt TM, Perea RJ, Xaubet A. Pulmonary sarcoidosis: Typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010 October; 30(6):1567–1586.
   PubMed Web of Science ®Google Scholar
• Udwadia ZF, Pilling JR, Jenkins PF, Harrison BD. Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 1990 April; 45(4):272–275.
   PubMed Web of Science ®Google Scholar
• Judson MA, Strange C. Bullous sarcoidosis: A report of three cases. Chest 1998 November; 114(5):1474–1478.
   PubMed Web of Science ®Google Scholar
• Chambellan A, Turbie P, Nunes H, Brauner M, Battesti JP, Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: Bronchoscopy, function, and evolution. Chest 2005 February; 127(2):472–481.
   PubMed Web of Science ®Google Scholar
• Sharma OP, Izumi T. Airway obstruction in sarcoidosis. West J Med 1988 May; 148(5):568–569.
   PubMedGoogle Scholar
• Polychronopoulos VS, Prakash UB. Airway involvement in sarcoidosis. Chest 2009 November; 136(5):1371–1380.
   PubMed Web of Science ®Google Scholar
• Iannuzzi MC, Fontana JR. Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011 January 26; 305(4):391–399.
   PubMed Web of Science ®Google Scholar
• O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004 November; 201(2):167–180.
   PubMed Web of Science ®Google Scholar
• Xin-Min D, Qin-Zhi X, Yun-You D, Chun-Yan Z, Chao-Sheng P, Hao-Yong N, Yong-Qun L, Ji-Guang M, Zhou-Shan N, Hua-Song F. Impact of tracheal mucosa involvement on clinical characteristics of sarcoidosis. South Med J 2011 May; 104(5):315–318.
   PubMedGoogle Scholar
• Jackson DM, Norris AA, Eady RP. Nedocromil sodium and sensory nerves in the dog lung. Pulm Pharmacol 1989; 2(4):179–184.
   PubMedGoogle Scholar
• Tatar M, Sant’Ambrogio G, Sant’Ambrogio FB. Laryngeal and tracheobronchial cough in anesthetized dogs. J Appl Physiol 1994 June; 76(6):2672–2679.
   PubMedGoogle Scholar
• Lewis MM, Mortelliti MP, Yeager H Jr, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: Case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis 2002 June; 19(2):154–159.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Iannuzzi MC, Lower EE, Moller DR, Balkissoon RC, Winget DB, Judson MA. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002 October; 19(3):198–204.
   PubMed Web of Science ®Google Scholar
• Alberts C, van der Mark TW, Jansen HM. Inhaled budesonide in pulmonary sarcoidosis: A double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J 1995 May; 8(5):682–688.
   PubMed Web of Science ®Google Scholar
• du Bois RM, Greenhalgh PM, Southcott AM, Johnson NM, Harris TA. Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: A pilot study. Eur Respir J 1999 June; 13(6):1345–1350.
   PubMedGoogle Scholar
• Paramothayan NS, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 2000; (2):CD001114.
   Google Scholar
• Paramothayan NS, Lasserson JT, Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 2005 Apr 18;(2):CD001114.
   Google Scholar
• Highland KB, Retalis P, Coppage L, Schabel SI, Judson MA. Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis?. South Med J 1997 September; 90(9):911–914.
   PubMedGoogle Scholar
• Wyplosz B, Marijon E, Dougados J, Pouchot J. Sarcoidosis: An unusual cause of acute pericarditis. Acta Cardiol 2010 February; 65(1): 83–84.
   PubMed Web of Science ®Google Scholar
• Yanagitani N, Kotake M, Ishizuka T, Iwasaki Y, Sunaga N, Mori M. A case of neurosarcoidosis discovered in a patient complaining of chest pain. Nihon Kokyuki Gakkai Zasshi 2009 December; 47(12):1087–1092.
   PubMedGoogle Scholar
• McKinzie BP, Bullington WM, Mazur JE, Judson MA. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci 2010 January; 339(1):1–4.
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Harrington D, Major M, Simoff M, Popovich J, Maliarik M, Iannuzzi MC. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol 1996; 13(1):23–33.
   PubMedGoogle Scholar
• Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughman RP, Teirstein AS. The diagnostic pathway to sarcoidosis. Chest 2003 February; 123(2):406–412.
   PubMed Web of Science ®Google Scholar
• Wilsher M, Hopkins R, Zeng I, Cornere M, Douglas R. Prevalence of asthma and atopy in sarcoidosis. Respirology 2012 February; 17(2):285–290. doi: 10.1111/j.1440–1843.2011.02066.x.
   PubMedGoogle Scholar
• Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis (APES). Chest (in press).
   Google Scholar
• Judson MA. Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: A potential mechanism related to T-helper cytokine balance. Chest 2009 May; 135(5):1358–1359.
   PubMedGoogle Scholar
• Guilleminault L, Carré P, Beau-Salinas F, Taillé C, Dieudé P, Crestani B, Diot P, Marchand-Adam S. Asthma unmasked with tumor necrosis factor-α-blocking drugs. Chest 2011 October; 140(4):1068–1071.
   PubMedGoogle Scholar
• Ohrn MB, Sköld CM, van Hage-Hamsten M, Siqurdardottir O, Zetterstrom O, Eklund A. Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage. Respiration 1995; 62(3):136–142.
   PubMedGoogle Scholar
• Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003 March; 123(3):751–756.
   PubMed Web of Science ®Google Scholar
• Ziora D, Kaluska K, Kozielski J. An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis. Eur Respir J 2004 October; 24(4):609–614.
   PubMedGoogle Scholar
• O’Donnell DM, Moynihan J, Finlay GA, Keatings VM, O'Connor CM, McLoughlin P, Fitzgerald MX. Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 December; 156(6):1892–1896.
   PubMedGoogle Scholar
• Wilsher ML, Fergusson W, Milne D, Wells AU. Exhaled nitric oxide in sarcoidosis. Thorax 2005 November; 60(11):967–970.
   PubMedGoogle Scholar
• Choi J, Hoffman LA, Sethi JM, Zullo TG, Gibson KF. Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: A pilot feasibility study. Sarcoidosis Vasc Diffuse Lung Dis 2009 July; 26(2):98–109.
   PubMed Web of Science ®Google Scholar
• Oettgen HC, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001 March; 107(3):429–440.
   PubMedGoogle Scholar
• Hattori T, Konno S, Shigemura M, Matsuno K, Shimizu C, Shigehara K, Shijubo N, Hizawa N, Yamaguchi E, Nishimura M. Total serum IgE levels and atopic status in patients with sarcoidosis. Allergy Asthma Proc 2012 January–February; 33(1):90–94.
   PubMedGoogle Scholar
• Renston JP, Goldman ES, Hsu RM, Tomashefski JF Jr. Peripheral blood eosinophilia in association with sarcoidosis. Mayo Clin Proc 2000 June; 75(6):586–590.
   PubMedGoogle Scholar
• D’Ippolito R, Foresi A, Chetta A, Casalini A, Castagnaro A, Leone C, Olivieri D. Induced sputum in patients with newly diagnosed sarcoidosis: Comparison with bronchial wash and BAL. Chest 1999 June; 115(6):1611–1615.
   PubMedGoogle Scholar
• Allen RK, Pierce RJ, Barter CE. Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Sarcoidosis 1992 March; 9(1):54–59.
   PubMedGoogle Scholar
• Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. Chest 1983 November; 84(5):522–528.
   PubMed Web of Science ®Google Scholar
• Lynch JP3rd, Kazerooni EA, Gay SE.Pulmonary sarcoidosis. Clin Chest Med 1997 December; 18(4):755–785.
   PubMed Web of Science ®Google Scholar
• Mue S, Takahashi M, Ohmi T, Shibahara S, Yamauchi K, Fujimoto S, Okayama H, Takishima T. Serum angiotensin converting enzyme level in bronchial asthma. Ann Allergy 1978 January; 40(1):51–57.
   PubMedGoogle Scholar
• Judson MA, Gilbert GE, Rodgers JK, Greer CF, Schabel SI. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology 2008 January; 13(1):97–102.
   PubMed Web of Science ®Google Scholar
• Domingo C, Moreno A, Amengual MJ, Comet R, Lujan M. Twelve years’ experience with methotrexate for GINA treatment step 5 asthma patients. Curr Med Res Opin 2009 February; 25(2):367–374.
   PubMed Web of Science ®Google Scholar
• Comet R, Domingo C, Larrosa M, Moron A, Amengual MJ, Marin A. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study. Respir Med 2006 March; 100(3):411–419.
   PubMedGoogle Scholar
• Dean T, Dewey A, Bara A, Lasserson TJ, Walters EH. Azathioprine as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev 2004; (1):CD003270.
   Google Scholar